Structure of EBV GP340 768-782
Logo for Infectious disease
Infectious disease

EBV GP340 768-782 TGHGARTSTEPTTDY

€218.40*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP20306_5

Description

The peptide TGHGARTSTEPTTDY corresponds to amino acids 768–782 of the Epstein–Barr virus (EBV) envelope glycoprotein GP350/GP340, encoded by the BLLF1 gene (UniProt ID: P03200). This linear epitope (Epitope ID 419381) has been investigated for immune reactivity and has been experimentally validated in both a T cell assay and a MHC class II ligand assay, with reported HLA-DR3 restriction.

Envelope glycoprotein GP350/GP340

GP350/GP340 is one of the most abundant glycoproteins in the EBV envelope and plays a central role during viral attachment to B lymphocytes. Through molecular mimicry of complement components, GP350/GP340 binds to complement receptors CR1 (CD35) and CR2 (CD21) on the B cell surface, initiating virus attachment and subsequent endocytosis. The protein exists in multiple isoforms generated by alternative splicing, with GP350 representing the full-length form and GP340 corresponding to a truncated variant that retains the same biological function.

GP340 768–782 epitope

As a prominent surface antigen, GP350/GP340 is a major target of humoral and cellular immune responses and has been widely studied in the context of EBV infection, immune monitoring, and vaccine-related research. The GP340 768–782 epitope represents a CD4⁺ T cell–relevant region within this envelope glycoprotein and is suitable for investigating antigen presentation via HLA-DR molecules, T helper cell activation, and EBV-specific immune profiling.

The EBV GP340 768–782 peptide is well suited for applications such as T cell stimulation assays, MHC class II binding studies, ELISPOT/FluoroSpot assays, and epitope validation experiments. Produced under strict quality control standards, this peptide ensures high purity and batch-to-batch consistency, supporting robust and reproducible immunological research.

TechData

Sequence: TGHGARTSTEPTTDY
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 5 mg
Counterion: TFA
Protein: Envelope glycoprotein GP340
Species: Epstein-Barr virus (EBV; Human herpesvirus 4)
Application: Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication: Infectious disease, Cancer, Neuroscience
Purity: 95% HPLC-MS